We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Crystal Structure of CARDS Toxin Expected to Advance Respiratory Disease Treatment

By LabMedica International staff writers
Posted on 20 Apr 2015
Print article
Image: Molecular model of CARDS toxin, which was first described in 2006 (Photo courtesy of the University of Texas Health Science Center at San Antonio).
Image: Molecular model of CARDS toxin, which was first described in 2006 (Photo courtesy of the University of Texas Health Science Center at San Antonio).
A recent paper described the molecular structure of Mycoplasma pneumoniae's Community Acquired Respiratory Distress Syndrome (CARDS) toxin and explained how knowing this structure may lead to advances in the prevention and treatment of diseases caused by this respiratory pathogen.

Mycoplasma pneumoniae is a very small bacterium in the class Mollicutes. It is a human pathogen that causes the disease mycoplasma pneumonia, a form of atypical bacterial pneumonia related to cold agglutinin disease. The organism is characterized by the absence of a peptidoglycan cell wall and resulting resistance to many antibacterial agents. As part of the infectious process, the bacterium expresses the 591-amino acid long CARDS toxin virulence factor with both mono-ADP ribosyltransferase (mART) and vacuolating activities. CARDS toxin binds to human surfactant protein A and annexin A2 on airway epithelial cells and is internalized, leading to a range of pathological genetic events.

In a paper published in the April 7, 2015, online edition of the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS) investigators at the University of Texas Health Science Center (San Antonio, USA) presented the X-ray crystallography-derived structure of CARDS toxin. The results depicted a triangular molecule in which N-terminal mART and C-terminal tandem beta-trefoil domains associated to form an overall architecture distinct from other well-recognized ADP-ribosylating bacterial toxins. The investigators demonstrated that CARDS toxin bound phosphatidylcholine and sphingomyelin specifically over other membrane lipids, and that cell surface binding and internalization activities were housed within the C-terminal beta-trefoil domain.

Recombinant CARDS toxin administered to naive mice induced an allergic-type inflammatory response and airway hyperreactivity, suggesting that an analogous response in humans might play a causal role in M. pneumoniae-associated asthma.

"We know a lot about how the toxin works, but we did not have its three-dimensional structure," said contributing author Dr. Joel B. Baseman, professor of microbiology and immunology at the University of Texas Health Science Center. "The structure shows us the molecular architecture of the protein, which permits the rational design of effective drugs and vaccines to neutralize the injurious effects of CARDS toxin. Blocking the toxin could prove to be a major advance in the prevention and care of a wide range of acute and chronic airway diseases."

Related Links:

University of Texas Health Science Center


New
Gold Member
ANA & ENA Screening Assays
ANA and ENA Assays
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Urine Drug Test
Instant-view Methadone Urine Drug Test
New
Automated Nucleic Acid Extractor
eLab

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: The bowel cancer breakthrough could result in better treatment outcomes (Photo courtesy of 123RF)

New RNA Molecules Can Help Predict Bowel Cancer Return Recurrence

Colorectal cancer accounts for 10% of all cancer-related deaths worldwide and was ranked as the second most common cause of cancer death in the United States in 2022. Currently, clinicians face diagnostic... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Microbiology

view channel
Image: The InfectoSynovia test has the potential to revolutionize the diagnosis of periprosthetic joint infection (Photo courtesy of 123RF)

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more

Pathology

view channel
Image

AI-Based Method Shows Promise for Pathological Diagnosis of Hereditary Kidney Diseases

Alport syndrome is a hereditary kidney disorder characterized by kidney dysfunction, sensorineural hearing loss, and ocular abnormalities. Early in the disease, patients experience hematuria, which is... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.